Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers M > Headlines for Melinta Therapeutics, Inc. > News item |
Melinta posts $4.64 million loss from operations for Dec. 27-Jan. 31
By Caroline Salls
Pittsburgh, March 19 – Melinta Therapeutics, Inc. reported a $4.64 million loss from operations for the period of Dec. 27 through Jan. 31 on $3.28 million in total revenue, according to its monthly operating report filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.
The net loss for the period was $22.57 million.
In addition, Melinta listed $55.99 million in cash and cash equivalents as of Jan. 31.
Melinta is an antibiotics company based in New Haven, Conn. The company filed bankruptcy on Dec. 27 under Chapter 11 case number 19-12748.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.